Day: April 30, 2020

South Plains Financial, Inc. Reports First Quarter 2020 Financial Results

LUBBOCK, Texas, April 30, 2020 (GLOBE NEWSWIRE) — South Plains Financial, Inc. (NASDAQ:SPFI) (“South Plains” or the “Company”), the parent company of City Bank (“City Bank” or the “Bank”), today reported its financial results for the quarter ended March 31, 2020. First Quarter 2020 HighlightsNet income for the first quarter of 2020 was $7.1 million, compared to $4.8 million for the first quarter of 2019.Diluted earnings per share for the first quarter of 2020 was $0.38, compared to $0.32 for the first quarter of 2019.Average cost of deposits for the first quarter of 2020 declined 11 basis points to 65 basis points, compared to 76 basis points for the fourth quarter of 2019.The provision for loan losses in the first quarter of 2020 was $6.2mm, compared to $896,000 for the first quarter of 2019, due to the economic uncertainty related...

Continue reading

Terex Announces First Quarter 2020 Results

WESTPORT, Conn., April 30, 2020 (GLOBE NEWSWIRE) — Terex Corporation (NYSE: TEX) today announced a first quarter 2020 loss from continuing operations of $(24.7) million, or $(0.35) per share, on net sales of $833.6 million.  In the first quarter of 2019, the reported income from continuing operations was $57.2 million, or $0.79 per share, on net sales of $1.1 billion.  This compares to income from continuing operations, as adjusted, of $62.3 million or $0.87 per share in the first quarter of 2019. The Glossary at the end of this press release contains further details regarding these non-GAAP measures.John L. Garrison, Jr., Terex Chairman and CEO, commented, “First and foremost, we have taken measures to prioritize the health and safety of our team members, families and customers during the COVID-19 pandemic.”Mr. Garrison continued,...

Continue reading

Hanmi Reports First Quarter 2020 Results

2020 First Quarter Highlights:                    Net income of $2.4 million, or $0.08 per diluted share, down from $3.1 million, or $0.10 per diluted share for the prior quarter and down from $14.7 million or $0.48 per diluted share from the same quarter a year ago; 2020 first quarter results included credit loss expense of $15.7 million.Loans receivable of $4.54 billion, down 1.4% from the prior quarter and down 0.7% year-over-year reflecting the strategy of allowing residential mortgages to run-off and shifting the mix of the portfolio to higher-yielding loans; first quarter loan production up 16.0% from the same quarter last year.Deposits of $4.58 billion, down 2.5% from the prior quarter and down 4.9% year-over-year reflecting the decline in higher-costing time deposits; first quarter cost of interest-bearing deposits declined 19...

Continue reading

Fidus Investment Corporation Announces First Quarter 2020 Financial Results

EVANSTON, Ill., April 30, 2020 (GLOBE NEWSWIRE) — Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”), a provider of customized debt and equity financing solutions, primarily to lower middle-market companies based in the United States, today announced its financial results for the first quarter ended March 31, 2020.First Quarter 2020 Financial HighlightsTotal investment income of $20.0 millionNet investment income of $17.4 million, or $0.71 per shareAdjusted net investment income of $8.5 million, or $0.35 per share(1)Net decrease in net assets resulting from operations of $(27.0) million, or $(1.10) per shareInvested $68.2 million in debt and equity securities, including three new portfolio companiesReceived proceeds from repayments and realizations of $73.8 million, recognizing $30.3 million in net realized gainsPaid...

Continue reading

Exponent Declares Regular Quarterly Dividend

MENLO PARK, Calif., April 30, 2020 (GLOBE NEWSWIRE) — Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock to be paid on June 26, 2020 to all common stockholders of record as of June 12, 2020. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent’s Board of Directors.“In February our Board of Directors increased our cash dividend for the 7th consecutive year. Today we declared a quarterly cash dividend payment and reiterated our intent to continue paying dividends. We are committed to delivering value to our shareholders...

Continue reading

LeMaitre Vascular Announces Q1 2020 Financial Results

BURLINGTON, Mass., April 30, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2020 results and announced a $0.095/share quarterly dividend.Q1 2020 ResultsRecord sales of $30.6mm, +7% (-1% organic) vs. Q1 2019Operating income of $4.4mm, -2%Net income of $3.2mm, -10%Earnings of $0.16 per diluted share, -11%EBITDA of $5.7mm, +1%March 31, 2020 cash & equivalents of $30.6mmThe Company posted record sales in the Americas (+12%) and Europe/Middle East/Africa (+3%), offset by Asia/Pac (-11%). Sales growth was led by biologic patches, allografts and valvulotomes, and was aided by the two 2019 acquisitions.  Gross margin decreased to 67.0% in Q1 2020 (vs. 68.3% in Q1 2019) primarily due to manufacturing inefficiencies and increased allograft sales.Operating...

Continue reading

CoImmune, Inc., a US-Based Clinical-Stage Biotech, Completes Merger with Formula Pharmaceuticals, Inc.

DURHAM, N.C. , April 30, 2020 (GLOBE NEWSWIRE) — CoImmune, Inc. today announced that it has successfully completed the merger with Formula Pharmaceuticals, Inc., bringing together two therapeutic immuno-oncology platforms. Formula Pharmaceuticals merged into CoImmune with CoImmune as the surviving company.CoImmune will continue to focus on running a Phase 2b trial for lead asset, CMN-001, in advanced renal cell carcinoma. With the merger’s completion, CoImmune will use the newly acquired technology, CAR-CIK (cytokine-induced killer cells), for clinical development in acute lymphoblastic leukemia. The proprietary CAR-CIK technology platform derives from work mainly performed by the Tettamanti Foundation of Monza, Italy, in connection with one of the pioneering centers for cell therapy in Europe, located at the San Gerardo Hospital...

Continue reading

TELUS is #1 on the Heroes Leaderboard

VANCOUVER, British Columbia, April 30, 2020 (GLOBE NEWSWIRE) — Today, TELUS ranked first internationally as a leading corporate citizen for its efforts to support Canadians during the COVID-19 pandemic by DidTheyHelp.com. The Heroes leaderboard ranks global brands and individuals by awarding a point for each positive action and good deed they make. This third party recognition underpins the deep commitment TELUS team members have in keeping our citizens safe and connected during this health emergency and beyond.“I am exceptionally proud of the TELUS team’s incredible commitment to give where we live, which has earned TELUS an amazing first place ranking on the “Heroes Leaderboard”. This recognition is thanks to our team members and their incredibly generous contribution of time, funding and intellectual energy in support of those...

Continue reading

SMCP – 2019 Universal Registration Document available

Paris, April 30, 2020SMCP SA: Publication of the 2019 Universal Registration DocumentSMCP SA announces the publication of its 2019 Universal Registration Document (Document d’Enregistrement Universel 2019) including the annual financial report for the 2019 fiscal year, filed with the French Financial Markets Authority (the Autorité des Marchés Financiers – AMF) on April 30, 2020.The 2019 Universal Registration Document includes notably:the annual financial report for the fiscal year ended December 31, 2019the board of directors’ report on corporate governance pursuant to the provisions of Articles L.225-37 et seq. of the French Commercial codethe 2019 statement of non-financial performance (Déclaration de performance extra-financière – DPEF), as well as the Independent Supervisory Body’s Report thereonThe French and English versions of...

Continue reading

SMCP – Mise à disposition du Document d’Enregistrement Universel 2019

Paris, le 30 avril 2020SMCP SA : Mise à disposition du Document d’Enregistrement Universel 2019SMCP SA annonce la publication de son Document d’Enregistrement Universel 2019 incorporant le rapport financier annuel pour l’exercice clos le 31 décembre 2019, qui a été déposé auprès de l’Autorité des Marchés Financiers (AMF) le 30 avril 2020.Le Document d’Enregistrement Universel 2019 contient notamment :le rapport financier annuel pour l’exercice clos le 31 décembre 2019le rapport du Conseil d’Administration sur le gouvernement d’entreprise en application des dispositions des articles L.225-37 et suivants du Code de commerce la déclaration de performance extra-financière (DPEF) 2019 ainsi que le rapport de vérification de l’organisme indépendant y afférentLe Document d’Enregistrement Universel 2019 est disponible en version française et anglaise...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.